Symbicort is a prescription drug used to treat asthma and chronic obstructive pulmonary disease (COPD). Learn how to lower long-term costs and more.

The first Symbicort generic, simply referred to as budesonide/formoterol inhaler, was approved by the Food and Drug Administration (FDA) in February 2020 and is roughly half the cost of Symbicort.

Viatris announced the launch of Breyna ™ (budesonide and formoterol fumarate dihydrate) inhalation aerosol, the first generic version of AstraZeneca’s Symbicort ®.. Breyna is a metered-dose ...

Symbicort uses the corticosteroid budesonide, while Advair contains fluticasone. The long-acting beta 2 -adrenergic agonist in either drug helps relax the muscles around the airways in your lungs.

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

There is ongoing patent litigation between AstraZeneca, the maker of Symbicort, and Viatris, formerly known as Mylan Pharmaceuticals, and its drug delivery device partner Kindeva Drug Delivery LP.

AZ failed to show their generic names, and again there was mention of Symbicort in this section, but the page didn't include prescribing information or where to find it, so a further reprimand ...

Viatris' generic of Symbicort (budesonide and formoterol fumarate dihydrate) – developed by Viatris in collaboration with 3M spin-off company Kindeva Drug Delivery and called Breyna – has been ...

AstraZeneca Plc <AZN.L> shares fell more than 3 percent on Friday after the European Patent Office revoked a key patent on its key asthma drug Symbicort.

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain ...